2Singhal S. Cancer chemotherapy using suicide genes [ J ]. Surg Oncol Clin N Am, 1998, 7(3): 505-36.
3Loimas S, Toppinen MR, Visakorpi T, et al. Human prostate carcinoma cells as targets for herpes simplex virus thymidine kinasemediated suicide gene therapy[ J ]. Cancer Gene Ther, 2001, 8(2): 137-144.
4Bruder JT, Heidecker G, Tan TH, et al. Oncogene activation of HIV-LTR-driven expression via the NF-kappa B binding sites[ J]. Nucleic Acids Res, 1993, 21 (22): 5229-5234.
6Narita M, Bahar R, Hatano M, et al. Tissue-specific expression of a suicide gene for selective killing of neuroblastoma cells using a promoter region of the NCX gene[ J]. Cancer Gene Ther, 2001,8(12): 997-1002.
7Yu D, Chen D, Chiu C, et al. Prostate-specific targeting using PSA promoter-based lentiviral vectors[J]. Cancer Gene Ther, 2001,8(9): 628-635.
8Tanaka S, Iwai M, Harada Y, et al. Targeted killing of carcinoembryonic antigen (CEA)-producing cholangiocarcinoma cells by polyamidoamine dendrimer-mediated transfer of an Epstein-Barr virus (EBV) -based plasmid vector carrying the CEA promoter[ J ].Cancer Gene Ther, 2000, 7(9): 1241-1250.
9Cao G, Kuriyama S, Gao J, et al. Gene therapy for hepatocellularcarcinoma based on tumour-selective suicide gene-expression using the alpha-fetoprotein (AFP) enhancer and a housekeeping gene promoter[J]. Eur J Cancer. 2001,37(1): 140-147.
10Li JH, Chia M, Shi W, et al. Tumor-targeted gene therapy for nasopharyngeal carcinoma[ J]. Cancer Res, 2002, 62 ( 1 ): 171-178.
